SynDRA canonical compound SYN0000122 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HRH2 |
| Mechanism of action | Histamine receptor antagonist |
| Indication | aggressive systemic mastocytosis (ASM) | duodenal ulcer disease | endocrine adenoma | gastroesophageal reflux disease (GERD) | peptic ulcer disease (PUD) | Zollinger-Ellison syndrome |
| Disease area | endocrinology | gastroenterology | hematologic malignancy |